Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis

Neuroscience

Volumn 143, Issue 3, 2006, Pages 655-659

  Xu, K ^a   Jha, S ^a   Hoch, W ^a   Dryer, S E ^a  

^a University of Houston   (United States)

Author keywords

acetylcholine receptor; agrin; autoimmune disorders; muscle specific kinase; myasthenia gravis; neuromusculular junction

Indexed keywords

AGRIN; BIOLOGICAL MARKER; CHOLINERGIC RECEPTOR; ENZYME ANTIBODY; MUSCLE SPECIFIC KINASE; NEUROFILAMENT PROTEIN; NICOTINIC RECEPTOR; PROTEIN TYROSINE KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADDUCTOR LONGUS MUSCLE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIAPHRAGM; DISEASE PREDISPOSITION; FEMALE; IMMUNIZATION; INTERCOSTAL MUSCLE; MOUSE; MUSCLE; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STERNOCLEIDOMASTOID MUSCLE; SYNAPTOGENESIS; TIBIALIS ANTERIOR MUSCLE; TIBIALIS POSTERIOR MUSCLE;

AGRIN; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MUSCLES; MYASTHENIA GRAVIS; NEUROFILAMENT PROTEINS; NEUROMUSCULAR JUNCTION; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; RECEPTORS, NICOTINIC; SYNAPTOPHYSIN; TIME FACTORS;

EID: 33750969338     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.09.022     Document Type: Article

References (16)

1. Chevessier F., Faraut B., Ravel-Chapuis A., Richard P., Gaudon K., Bauché S., Prioleau C., Herbst R., Goillot E., Ioos C., Azulay J.P., Attarian S., Leroy J.P., Fournier E., Legay C., Schaeffer L., Koenig J., Fardeau M., Eymard B., Pouget J., and Hantai D. MUSK, a new target for mutations causing congenital myasthenic syndrome. Hum Mol Genet 13 (2004) 3229-3240
2. Christadoss P., Poussin M., and Deng C. Animal models of myasthenia gravis. Clin Immunol 94 (2000) 75-87
3. DeChiara T.M., Bowen D.C., Valenzuela D.M., Simmons M.V., Poueymirou W.T., Thomas S., Kinetz E., Compton D.L., Rojas E., Park J.S., Smith C., DiStefano P.S., Glass D.J., Burden S.J., and Yancopoulos G.D. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85 (1996) 501-512
4. Evoli A., Tonali P., Padua L., Lo Monaco M., Scuderi F., Batocchi A., and Marino M. Clin correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. EB. Brain 126 (2003) 2304-2311
5. Hoch W. Formation of the neuromuscular junction: Agrin and its unusual receptors. Eur J Biochem 265 (1999) 1-10
6. Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., and Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patents with myasthenia gravis without acetylcholine receptor. Nat Med 7 (2001) 365-368
7. Jha S., Xu K.P., Maruta T., Oshima M., Mosier D., Atassi M.Z., and Hoch W. Myasthenia gravis generated in mice by inducing the synthesis of auto-antibodies directed against the muscle-specific kinase (MuSK). J Neuroimmunol 175 (2006) 107-117
8. Kong X.C., Barzaghi P., and Ruegg M.A. Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBO Rep 5 (2004) 183-188
9. Kurihara T. Seronegative myasthenia gravis and muscle atrophy of the tongue. Internal Medicine 44 (2005) 536-537
10. Lennon V.A., Seybold M.E., Lindstrom J.M., Cochrane C., and Ulevitch R. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J Exp Med 147 (1978) 973-983
11. Nemoto Y., Kuwabara S., Misawa S., Kuwaguchi T., Hattori T., Takamori M., and Vincent A. Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J Neurol Neurosurg Psychiatry 76 (2005) 714-718
12. Padua L., Tonali P., Aprile I., Caliandro P., Bartoccioni E., and Evoli A. Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK- patients. Eur J Neurol 13 (2006) 273-276
13. Pun S., Sigrist M., Santos A., Ruegg M., Sanes J.R., Jessel T.M., and Arber S. An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles. Neuron 34 (2002) 357-370
14. Sanes J.R., and Lichtman J.W. Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci 2 (2001) 791-805
15. Selcen D., Fukuda T., Shen X.M., and Engel A.G. Are MuSK antibodies the primary cause of myasthenic symptoms?. Neurology 62 (2004) 1945-1950
16. Shiraishi H., Motomura M., Yoshimura T., Fukudoma T., Fukuda T., Nakao Y., Tsujihata M., Vincent A., and Eguchi K. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Annals of Neurology 57 (2005) 289-293